ALAB · 深度研究报· In-Depth Research Report告
Q4营收$2.706亿同比增长92%超预期、全年2025营收$8.525亿同比增长115%、Q1 2026指引$2.86亿至$2.97亿大幅超华尔街预期约15%、Scorpio X系列量产正式启动、aiXscale Photonics收购延伸光学互联版图、Amazon $65亿累计采购战略绑定——股价从财报前约$172大幅回落至今天约$109：三重短期情绪冲击制造的错杀，正在为AI数据中心连接芯片全球唯一垂直整合平台提供一个以折价建仓的历史性窗口
Q4 revenue of $270.6 million grew 92% year-over-year and beat expectations; full-year 2025 revenue of $852.5 million grew 115% year-over-year; Q1 2026 guidance of $286 million to $297 million significantly exceeded prior Wall Street expectations by approximately 15%; Scorpio X series mass production officially launched; aiXscale Photonics acquisition extended the optical interconnect product map; Amazon's $6.5 billion cumulative procurement strategic binding — shares have pulled back sharply from approximately $172 before earnings to approximately $109 today: a mispricing created by three short-term sentiment shocks is providing a historic discounted entry window into the world's only vertically integrated platform for AI data center connectivity chips
2026年2月10日。Astera Labs发布Q4 2025财报。营收$2.706亿，同比增长92%，环比增长17%，超华尔街共识预期约8%。Non-GAAP每股收益$0.58，超预期$0.51约14%。Q1 2026指引$2.86亿至$2.97亿，超华尔街此前预期约15%，是公司上市以来单季指引超预期幅度最大的一次。CEO Jitendra Mohan在财报电话会上表示："越来越多的瓶颈正在从计算转向连接，而连接正是我们的战场。AI仍处于非常早期的阶段。"
On February 10, 2026, Astera Labs released its Q4 2025 earnings report. Revenue of $270.6 million grew 92% year-over-year and 17% quarter-over-quarter, beating Wall Street consensus expectations by approximately 8%. Non-GAAP EPS of $0.58 beat the expected $0.51 by approximately 14%. Q1 2026 guidance of $286 million to $297 million exceeded prior Wall Street expectations by approximately 15%, representing the largest single-quarter guidance beat since the company's IPO. CEO Jitendra Mohan stated on the earnings call: "More and more bottlenecks are shifting from compute to connectivity, and connectivity is our battlefield. AI is still in a very early stage."
然后，股价跌了。CFO Mike Tate宣布离职、Amazon新增认股权证引发的毛利率阶段性压力、以及部分激进机构对营收超越$2.8亿的预期落空，三重短期情绪冲击叠加，将一份全面超预期的财报变成了一次深度错杀。股价从财报前约$172跌至今天约$109，跌幅超过36%。
Then the stock fell. The announcement of CFO Mike Tate's departure, the phased gross margin pressure triggered by the new Amazon warrants, and the disappointment of certain aggressive institutional expectations for revenue to exceed $280 million — three short-term sentiment shocks combined to turn a comprehensively beat earnings report into a deep mispricing. The stock fell from approximately $172 before earnings to approximately $109 today, a decline of more than 36%.
同一家公司。同一份财报。营收同比增长92%，全年增长115%，Q1指引大幅超预期——却换来股价暴跌36%。这正是为什么今天的Astera Labs是全球AI基础设施投资领域最具争议的定价错误之一。当你以约$109买入ALAB，你并不是在买一家即将见顶的半导体公司——你是在以折价参与一家刚刚完成从「单产品线信号调节供应商」向「多引擎AI连接全平台」战略升级的公司，而这场升级最重要的催化剂——Scorpio X系列放量、Leo CXL营收认列、UALink产品推出——在今天都还没有完全兑现。
The same company. The same earnings report. Revenue growing 92% year-over-year, full-year growth of 115%, Q1 guidance significantly beating expectations — yet the stock fell 36%. This is precisely why today's Astera Labs is one of the most debated pricing mistakes in the global AI infrastructure investment landscape. When you buy ALAB at approximately $109, you are not buying a semiconductor company that is about to peak — you are participating at a discount in a company that has just completed a strategic upgrade from a "single-product-line signal conditioning supplier" to a "multi-engine AI connectivity full platform," and the most important catalysts for this upgrade — Scorpio X series volume ramp, Leo CXL revenue recognition, UALink product launch — have not yet been fully realized today.
19位华尔街分析师覆盖ALAB，17位买入，5位持有，零个卖出。中位目标价$205，最高目标价$250（花旗集团Atif Malik），对应当前股价潜在升幅分别约+88%与+129%。连最保守的分析师目标价$155（巴克莱Tom O'Malley）也对应超过+42%的潜在升幅——在今天约$109的股价下，华尔街没有一位分析师认为ALAB是卖出。
19 Wall Street analysts cover ALAB, with 17 Buy ratings, 5 Hold ratings, and zero Sell ratings. The median target price is $205, and the highest target price is $250 from Citigroup's Atif Malik, implying approximately +88% and +129% upside from the current stock price respectively. Even the most conservative analyst's target price of $155 from Barclays' Tom O'Malley implies more than +42% potential upside — at today's stock price of approximately $109, not a single Wall Street analyst considers ALAB a Sell.
本报告将深入拆解Astera Labs的四大核心投资逻辑、关键催化剂时间节点、华尔街多空双方最新目标价对比，以及我们独立得出的12至24个月目标价区间——数字或许会让你意外。
This report will break down Astera Labs' four core investment pillars, key catalyst timelines, the latest Wall Street bull and bear target price comparisons, and our independently derived 12- to 24-month target price range — and the numbers may surprise you.
